Epidemiology of Cardiovascular Disease in Pregnancy in Japan - Analysis of a Nationwide Perinatal Database 2014-2023

Masafumi Nii1, Shoko Chishaki-Kawabata2, Koshiro Kanaoka2

  • 1Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine.

Insights

Approximately 1.23% of pregnancies in Japan involve cardiovascular disease (CVD). Women with CVD experienced more interventions and a slightly increased risk of maternal complications and death, highlighting the need for careful monitoring.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a growing cause of maternal health issues globally.
  • Limited contemporary data exists on CVD complications in Japanese pregnancies.

Purpose of the Study:

  • To analyze nationwide data on maternal cardiovascular disease in Japan.
  • To assess the impact of CVD on pregnancy outcomes and interventions.

Main Methods:

  • Retrospective cohort study using the Japan Society of Obstetrics and Gynecology Perinatal Database (2014-2023).
  • Compared 26,894 pregnancies with CVD against a low-risk population (n=1,882,896).

Main Results:

  • 1.23% of pregnancies were complicated by maternal CVD.
  • CVD pregnancies had lower parity, more cesarean deliveries, general anesthesia, and labor analgesia.
  • Higher rates of hypertensive disorders, pulmonary embolism, and pulmonary edema were observed in pregnancies with CVD.
  • Maternal death was rare but more frequent in pregnancies with CVD (0.03% vs 0.01%).
  • Neonatal outcomes were similar between groups.

Conclusions:

  • Maternal CVD affects approximately 1% of pregnancies in Japan.
  • Women with CVD require more obstetric and anesthetic interventions.
  • There is a modestly increased risk of maternal morbidity and mortality in pregnancies with CVD.
  • Findings support continued registry surveillance for risk-stratified perinatal care.
Abstract

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...